Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Dec. 11, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 11, 2013

AbbVie, Avanir, Baxter, Genzyme, KaloBios, Merck, Orexigen, QRxPharma, Seattle Genetics

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
KaloBios succeeds in early-stage trial . . . read more

Phase II
Seattle Genetics updates Adcetris DLBCL data . . . read more

Phase III
AbbVie regimen wallops HCV . . . read more

Avanir pain drug misses endpoint in MS pain trial . . . read more

Merck advances Alzheimer’s drug . . . read more

Filings
Baxter submits OBI-1 BLA . . . read more

Genzyme Gaucher treatment gets priority review . . . read more

Orexigen resubmits Contrave NDA . . . read more

QRxPharma MOXDUO PDUFA date announced . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics